July 31, 1998
The authors acknowledge the substantive contributions of Thomas A. Farley, M.D., M.P.H., Louisiana Office of Public Health, and Deborah A. Cohen, M.D., M.P.H., Louisiana State University.
2. Royce RA, Sena A, Cates W Jr, Cohen MS. Sexual transmission of HIV. N Engl J Med 1997; 336:1072-8.
3. Cameron DW, Simonsen JN, D'Costa LJ, et al. Female to male transmission of human immunodeficiency virus type 1: risk factors for seroconversion in men. Lancet 1989;403-7.
4. Telzak EE, Chiasson MA, Bevier PJ, Stoneburner RL, Castro KG, Jaffe HW. HIV-1 seroconversion in patients with and without genital ulcer disease. A prospective study. Ann Intern Med 1993; 119:1181-6.
5. Plummer FA, Simonsen JN, Cameron DW, et al. Cofactors in male-female sexual transmission of human immunodeficiency virus type 1. J Infect Dis 1991;163:233-9.
6. De Vincenzi I, European Study Group on Heterosexual Transmission of HIV. A longitudinal study of human immunodeficiency virus transmission by heterosexual partners. N Engl J Med 1994;331:341-6.
7. Kassler WJ, Zenilman JM, Erickson B, Fox R, Peterman TA, Hook EW III. Seroconversion in patients attending sexually transmitted disease clinics. AIDS 1994;8:351-5.
8. Otten MW Jr, Zaidi AA, Peterman TA, Rolfs RT, Witte JJ. High rate of HIV seroconversion among patients attending urban sexually transmitted disease clinics. AIDS 1994;8:549-53.
9. Craib KJ, Meddings DR, Strathdee SA, et al. Rectal gonorrhoea as an independent risk factor for HIV infection in a cohort of homosexual men. Genitourin Med 1995;71:150-4.
10. Laga M, Alary M, Nzila N, et al. Condom promotion, sexually transmitted diseases treatment, and declining incidence of HIV-1 infection in female Zairian sex workers. Lancet 1994;344: 246-8.
11. Mehendale SM, Rodrigues JJ, Brookmeyer RS, et al. Incidence and predictors of human immunodeficiency virus type 1 seroconversion in patients attending sexually transmitted disease clinics in India. J Infect Dis 1995;172:1486-91.
12. Holmberg SD, Stewart JA, Gerber AR, et al. Prior herpes simplex virus type 2 infection as a risk factor for HIV infection. JAMA 1988;259:1048-50.
14. Plummer FA, Wainberg MA, Plourde P, et al. Detection of human immunodeficiency virus type 1 (HIV-1) in genital ulcer exudate of HIV-1-infected men by culture and gene amplification [Letter]. J Infect Dis 1990;161:810-1.
15. Kreiss JK, Coombs R, Plummer F, et al. Isolation of human immunodeficiency virus from genital ulcers in Nairobi prostitutes. J Infect Dis 1989;160:380-4.
17. Ghys PD, Fransen K, Diallo MO, et al. The associations between cervicovaginal HIV shedding, sexually transmitted diseases and immunosuppression in female sex workers in Abidjan, Côte d'Ivoire. AIDS 1997;11:F85-F93.
18. Atkins MC, Carlin EM, Emery VC, Griffiths PD, Boag F. Fluctuations of HIV load in semen of HIV positive patients with newly acquired sexually transmitted diseases. BMJ 1996;313:341-2.
19. Clemetson DBA, Moss GB, Willerford DA, et al. Detection of HIV DNA in cervical and vaginal secretions. Prevalence and correlates among women in Nairobi, Kenya. JAMA 1993;269: 2860-4.
20. Cohen MS, Hoffman IF, Royce RA, et al. Reduction of concentration of HIV-1 in semen after treatment of urethritis: implications for prevention of sexual transmission of HIV-1. Lancet 1997;349:1868-73.
21. Dickover RE, Garratty EM, Herman SA, et al. Identification of levels of maternal HIV-1 RNA associated with risk of perinatal transmission. Effect of maternal zidovudine treatment on viral load. JAMA 1996;275:599-605.
23. Levine WC, Pope V, Bhoomkar A, et al. Increase in endocervical CD4 lymphocytes among women with nonulcerative sexually transmitted diseases. J Infect Dis 1998;177:167-74.
24. Grosskurth H, Mosha F, Todd J, et al. Impact of improved treatment of sexually transmitted diseases on HIV infection in rural Tanzania: randomised controlled trial. Lancet 1995;346:530-6.
25. Gilson L, Mkanje R, Grosskurth H, et al. Cost-effectiveness of improved treatment services for sexually transmitted diseases in preventing HIV-1 infection in Mwanza Region, Tanzania. Lancet 1997;350:1805-9.
26. Wawer MJ, Sewankambo NK, Gray RH, et al. Community-based trial of mass STD treatment for HIV control, Rakai, Uganda: preliminary data on STD declines [Abstract no. MoC.443]. Vol.1. XIth International Conference on AIDS. Vancouver, Canada, July 7-12,1996;39.
27. Wawer MJ. The Rakai randomized, community-based trial of STD control for AIDS prevention: no effect on HIV incidence despite reductions in STDs [Abstract no. 12473]. In Conference Supplement, of the 12th World AIDS Conference. Geneva, Switzerland, June 28-July 3,1998;9.
28. Wawer MJ, Serwadda D, Gray RH, et al. Trends in HIV-1 prevalence may not reflect trends in incidence in mature epidemics: data from the Rakai population-based cohort, Uganda. AIDS 1997;11:1023-30.
29. Hayes R, Wawer M, Gray R, et al. Randomised trials of STD treatment for HIV prevention: Report of an international workshop. Genitourin Med 1997;73:432-43.
31. Boily MC, Anderson RM. Human immunodeficiency virus transmission and the role of other sexually transmitted diseases. Measures of association and study design. Sex Transm Dis 1996;23:312-32.
32. Boily MC. Transmission dynamics of coexisting chlamydial and HIV infections in the United States. In Eng TR, Butler WT, eds. The hidden epidemic. Confronting sexually transmitted diseases. Washington, DC: National Academy Press, 1997:316-29.
33. Boily MC, Brunham RC. The impact of HIV and other STDs on human populations. Are predictions possible? Infect Dis Clin North Am 1993;7:771-92.
34. Robinson NJ, Mulder DW, Auvert B, Hayes RJ. Proportion of HIV infections attributable to other sexually transmitted diseases in a rural Ugandan population: simulation model estimates. Int J Epidemiol 1997;26:180-9.
35. Garnett GP, Anderson RM. Strategies for limiting the spread of HIV in developing countries: conclusions based on studies of the transmission dynamics of the virus. J Acquir Immune Defic Syndr Hum Retrovirol 1995;9:500-13.
36. Over M, Piot P. Human immunodeficiency virus infection and other sexually transmitted diseases in developing countries: public health importance and priorities for resource allocation. J Infect Dis 1996;174(suppl 2):162-75.
37. The World Bank. Confronting AIDS: Public priorities in a global epidemic. Washington DC: The International Bank for Reconstruction and Development/The World Bank 1997;1-14.
38. Nelson KE, Celentano DD, Eiumtrakol S, et al. Changes in sexual behavior and a decline in HIV infection among young men in Thailand. N Engl J Med 1996;335:297-303.
39. Institute of Medicine. The hidden epidemic. Confronting sexually transmitted diseases. Washington, DC: National Academy Press, 1997:1-54.
40. CDC. Sexually transmitted diseases surveillance, 1996. Atlanta: U.S. Department of Health and Human Services, Public Health Service, CDC, 1997.
41. CDC. Ten leading nationally notifiable infectious diseases -- United States, 1995. MMWR 1996; 45:883-4.
43. CDC. Chlamydia prevalence and screening practices -- San Diego County, California 1993. MMWR 1994;43:366-9.
45. Fleming DT, McQuillan GM, Johnson RE, et al. Herpes simplex virus type 2 in the United States, 1976 to 1994. N Engl J Med 1997;337:1105-11.
46. CDC. Recommendations for the prevention and management of Chlamydia trachomatis infections, 1993. MMWR 1993;42(No. RR-12):1-39.
47. CDC. Gonorrhea among men who have sex with men -- selected sexually transmitted disease clinics, 1993-1996. MMWR 1997;46:889-92.
48. Lafferty WE, Hughes JP, Handsfield HH. Sexually transmitted diseases in men who have sex with men. Acquisition of gonorrhea and nongonococcal urethritis by fellatio and implications for STD/HIV prevention. Sex Transm Dis 1997;24:272-8.
50. Torian LV, Weisfuse IB, Makki HA, Benson DA, DiCamillo LM, Toribio FE. Increasing HIV-1 seroprevalence associated with genital ulcer disease, New York City, 1990-1992. AIDS 1995; 9:177-81.
51. Campos-Outcalt D, Ryan K. Prevalence of sexually transmitted diseases in Mexican-American pregnant women by country of birth and length of time in the United States. Sex Transm Dis 1995;22:78-82.
52. Edlin BR, Irwin KL, Faruque S, et al. Intersecting epidemics -- crack cocaine use and HIV infection among inner-city young adults. Multicenter Crack Cocaine and HIV Infection Study Team. N Engl J Med 1994;331:1422-7.
53. Rolfs RT, Joesoef MR, Hendershot EF, et al. A randomized trial of enhanced therapy for early syphilis in patients with and without human immunodeficiency virus infection. N Engl J Med 1997;337:307-14.
54. CDC. Outbreak of primary and secondary syphilis -- Baltimore City, Maryland 1995. MMWR 1996;45:166-9.
55. St. Louis ME, Farley TA, Aral SO. Untangling the persistence of syphilis in the South. Sex Transm Dis 1996;23:1-4.
56. Mertz KJ, Weiss JB, Webb RM, et al. An investigation of genital ulcers in Jackson, Mississippi, with use of a multiplex polymerase chain reaction assay: high prevalence of chancroid and human immunodeficiency virus infection. J Infect Dis 1998;178 (in press).
57. Diaz T, Chu SY, Conti L, et al. Risk behaviors of persons with heterosexually acquired HIV infection in the United States: results of a multistate surveillance project. J Acquir Immune Defic Syndr Hum Retrovirol 1994;7:958-63.
58. Belongia EA, Danila RN, Angamuthu V, et al. A population-based study of sexually transmitted disease incidence and risk factors in human immunodeficiency virus-infected people. Sex Transm Dis 1997;24:251-6.
59. Ruiz J, Facer M, Sun RK. Risk factors for human immunodeficiency virus infection and unprotected anal intercourse among young men who have sex with men. Sex Transm Dis 1998; 25:100-7.
60. Gourevitch MN, Hartel D, Schoenbaum EE, et al. A prospective study of syphilis and HIV infection among injection drug users receiving methadone in the Bronx, NY. Am J Public Health 1996;86:1112-5.
61. Wortley PM, Fleming PL. AIDS in women in the United States. Recent trends. JAMA 1997; 278:911-6.
62. CDC. Update: trends in AIDS incidence -- United States, 1996. MMWR 1997;46:861-7.
63. Mastro TD, De Vincenzi I. Probabilities of sexual HIV-1 transmission. AIDS 1996;10:S75-S82.
64. St. Louis ME, Wasserheit JN, Gayle HD. Janus considers the HIV pandemic -- harnessing recent advances to enhance AIDS prevention [Editorial]. Am J Public Health 1997;87:10-2.
65. Landry DJ, Forrest JD. Public health departments providing sexually transmitted disease services. Fam Plann Perspect 1996;28:261-6.
66. Battelle Institute. Evaluation of STD clinic flow and utilization -- final report. Arlington, Virginia: Battelle, Centers for Public Health Research and Education, 1993;contract no. 200-88-0642.
67. CDC. HIV prevention practices of primary-care physicians -- United States, 1992. MMWR 1994; 42:988-92.
68. DeLisle S. Preserving reproductive choice: Preventing STD-related infertility in women. SIECUS Report 1997;25:18-21.
69. CDC. Recommendations of the U.S. Public Health Service Task Force on the use of zidovudine to reduce perinatal transmission of human immunodeficiency virus. MMWR 1994;43(No. RR-11): 1-20.
71. CDC. Guidelines for the prevention and control of congenital syphilis. MMWR 1988;37(suppl): 1-13.
72. Moran JS, Kaufman JA, Felsenstein D. Survey of health care providers: who sees patients needing STD services, and what services do they provide? Sex Transm Dis 1995;22:67-9.
73. Gunn RA, Veinbergs E, Friedman LS. Adolescent health care providers. Establishing a dialogue and assessing sexually transmitted disease prevention practices. Sex Transm Dis 1997;24:90-3.
74. Gunn RA, Rolfs RT, Greenspan JR, Wasserheit JN. The changing paradigm of sexually transmitted disease control in the era of managed health care: developing partnerships to implement a community-wide population-oriented approach. JAMA 1998;279:680-4.
75. CDC. Prevention and managed care: opportunities for managed care organizations, purchasers of health care, and public health agencies. MMWR 1995;44(No.RR-14):1-12.
76. CDC. 1998 Guidelines for treatment of sexually transmitted diseases. MMWR 1998;47(No. RR-1): 1-111.
77. Blank S, McDonnell DD, Rubin SR, et al. New approaches to syphilis control. Finding opportunities for syphilis treatment and congenital syphilis prevention in a women's correctional setting. Sex Transm Dis 1997;24:218-26.
78. Wasserheit JN, Aral SO. The dynamic topology of sexually transmitted disease epidemics: implications for prevention strategies. J Infect Dis 1996;174:S201-S213.
79. Rietmeijer CA, Yamaguchi KJ, Ortiz CG, et al. Feasibility and yield of screening urine for Chlamydia trachomatis by polymerase chain reaction among high-risk male youth in field-based and other nonclinic settings. A new strategy for sexually transmitted disease control. Sex Transm Dis 1997;24:429-35.
80. Gunn RA, Podschun GD, Fitzgerald S, et al. Screening high-risk adolescent males for Chlamydia trachomatis infection: obtaining urine specimens in the field. Sex Transm Dis 1998;25:49-52.
82. Emmons WW, Paparello SF, Decker CF, Sheffield JM, Lowe-Bey FH. A modified ELISA and Western Blot accurately determine anti-human immunodeficiency virus type 1 antibodies in oral fluids obtained with a special collecting device. J Infect Dis 1995;171:1406-10.
83. Kassler WJ, Dillon BA, Haley C, Jones WK, Goldman A. On-site, rapid HIV testing with same-day results and counseling. AIDS 1997;11:1045-51.
84. National Institute of Justice and CDC. 1994 Update: HIV/AIDS and STDs in Correctional Facilities. U.S. Department of Justice, Office of Justice Programs, National Institute of Justice and U.S. Department of Health and Human Services, Public Health Service, CDC, 1995;NCJ156832:1-63.
85. CDC. Assessment of sexually transmitted diseases services in city and county jails -- United States, 1997. MMWR 1998;47:429-31.
86. Beltrami JF, Cohen DA, Hamrick JT, Farley TA. Rapid screening and treatment for sexually transmitted diseases in arrestees: a feasible control measure. Am J Public Health 1997;87: 1423-6.
87. Phillips RS, Hanff PA, Wertheimer A, Aronson MD. Gonorrhea in women seen for routine gynecologic care: criteria for testing. Am J Med 1988;85:177-82.
88. Schachter J, Stoner E, Moncada J. Screening for chlamydial infections in women attending family-planning clinics. West J Med 1983;138:375-9.
89. Handsfield HH, Lipman TO, Harnisch JP, Tronca E, Holmes KK. Asymptomatic gonorrhea in men. Diagnosis, natural course, prevalence, and significance. N Engl J Med 1974;290:117-23.
90. Alexander-Rodriguez T, Vermund SH. Gonorrhea and syphilis in incarcerated urban adolescents: prevalence and physical signs. Pediatrics 1987;80:561-4.
91. Ellerbeck EF, Vlahov D, Libonati JP, Salive ME, Brewer TF. Gonorrhea prevalence in Maryland state prisons. Sex Transm Dis 1989;16:165-7.
92. Grosskurth H, Mayaud P, Mosha F, et al. Asymptomatic gonorrhea and chlamydial infection in rural Tanzanian men. BMJ 1996;312:277-80.
93. U.S. Preventive Services Task Force. Guide to clinical preventive services, 2nd ed. Baltimore, Maryland: Williams & Wilkins, 1996.
94. Hessol NA, Priddy FH, Bolan G, et al. Management of pelvic inflammatory disease by primary-care physicians. A comparison with Centers for Disease Control and Prevention guidelines. Sex Transm Dis 1996;23:157-63.
95. American Medical Association. Guidelines for adolescent preventive services. Chicago, IL: American Medical Association, 1992.
96. Mertz KJ, Levine WC, Mosure DJ, Berman SM, Dorian KJ, Hadgu A. Screening women for gonorrhea: demographic screening criteria for general clinical use. Am J Public Health 1997; 87:1535-8.
97. CDC. Public Health Service guidelines for counseling and antibody testing to prevent HIV infection and AIDS. MMWR 1987;36:509-15.
98. St.Louis ME, Wasserheit JN. Elimination of syphilis in the United States. Science 1998;280: 353-4.
99. Valdiserri RO, Aultman TV, Curran JW. Community planning: a national strategy to improve HIV prevention programs. J Community Health 1995;20:87-100.
100. Levine WC. The complementary roles of case reporting and prevalence monitoring in STD surveillance [Abstract]. In Proceedings of the 1996 National STD Prevention Conference, Tampa, FL: US Department of Health and Human Services, Public Health Service, CDC and the American Social Health Association, 1996;A4:65.
101. Mertz KJ, Blank S, Courtney JG, et al. A system for monitoring STD prevalence among persons admitted to jails and juvenile detention facilities in the United States [Abstract]. In Proceedings of the International Congress of Sexually Transmitted Diseases, Seville, Spain: International Society of Sexually Transmitted Disease Research 1997;1:117, P335.
102. Taha TE, Kumwenda N, Liomba G, Miotti PG, Hoover DR, Mtimavalye LAR, Broadhead RL, Dallabetta GA, Yang L-P, Chiphangwi JD. Bacterial vaginosis and disturbances of vaginal flora: association with increased acquisition of HIV. AIDS 1998 (in press).
103. Karon JM, Rosenberg PS, McQuillan G, Khare M, Gwinn M, Petersen LR. Prevalence of HIV infection in the United States, 1984 to 1992. JAMA 1996;276:126-31.